Consuming dietary supplements containing curcumin has been shown to decrease the circulating levels of IAPP and GSK-3β. This finding introduces a new potential pathway by which curcumin might help to lower markers associated with insulin resistance, thereby possibly reducing the risk of T2D and AD. The gene discussed is IAPP; the disease is Insulin resistance.